Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
Date:3/11/2008

other current assets 1,140,000 1,188,000

Total current assets 24,913,000 19,898,000

PROPERTY:

Leasehold improvements 669,000 646,000

Laboratory equipment 3,756,000 3,533,000

Furniture, fixtures and office equipment 913,000 873,000

5,338,000 5,052,000

Less accumulated depreciation and

amortization (3,537,000) (3,212,000)

Property, net 1,801,000 1,840,000

Other assets 1,527,000 1,259,000

TOTAL ASSETS $28,241,000 $22,997,000

PEREGRINE PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (continued)

JANUARY 31, APRIL 30,

2008 2007

Unaudited

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:

Accounts payable $2,387,000 $1,683,000

Accrued clinical trial site fees 244,000 228,000

Accrued legal and accounting fees 390,000 392,000

Accrued royalties and license fees 124,000 337,000

Accrued payroll and related costs 858,000 874,000

Notes payable, current portion - 379,000

Capital lease obligation, current portion 17,000 17,000

Deferred revenue 1,434,000 1,060,000

Other current liabilities 1,239,000 885,000

Total current liabilities 6,693,000 5,855,000

Notes pay
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
5. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
6. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
7. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... VEGAS, Dec. 16 Cord Blood America, ... blood stem cell preservation company ( http://www.cordblood-america.com ... of stem cells, a biological insurance policy, to ... has reduced its debt by a total of ... of 2009 and total debt eliminated for the ...
(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), ... and Mr. David Pendarvis to its board of ... ,, Kenneth F. Buechler, Ph.D., was president, chief ... 1988 to 1994, Dr. Buechler was Biosite,s director ... was a senior research scientist for the diagnostics ...
(Date:12/16/2009)... HSP A has been found to be effectinve in improving yelds ... ... -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand ... manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy ... HSP-A has been found to be especially effective in improving ...
(Date:12/15/2009)... Dec. 15 Repligen Corporation (Nasdaq: ... received $731,000 in research funding to support the ... from the Muscular Dystrophy Association (MDA). This ... toxicology testing and GMP manufacture of a drug ... the MDA not only provides important funding for ...
Breaking Biology Technology:Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... Multiple presentations included Resverlogix data, TSX Exchange ... Resverlogix Corp.,("Resverlogix" or the "Company") (TSX:RVX) is pleased ... data pertaining to its lead compound,RVX-208, at the ... presentation titled "RVX-208 a novel small molecule that ...
... BioIT Alliance Dedicated to Advancing Personalized Medicine by Improving ... ... Waters Corporation,(NYSE: WAT ) today announced that it ... involving more than 80,pharmaceutical, biotech, laboratory instrument and software companies,working ...
... Sept. 2 StopAfib.org, at, http://www.StopAfib.org, announces that ... life-threatening irregular heartbeat,commonly called afib or AF., Once ... congestive heart failure or stroke. Every five minutes, someone ... is our #3 killer and the #1 cause of,permanent ...
Other Biology Technology:ApoA-I Data Presented at European Society of Cardiology Congress 2Waters Brings Advanced Laboratory Data Management to Microsoft's BioIT Alliance 2Waters Brings Advanced Laboratory Data Management to Microsoft's BioIT Alliance 3Atrial Fibrillation Month - StopAfib.org Announces September Focus on Life-Threatening Irregular Heartbeat 2
(Date:12/15/2009)... -- The 2009 Frost & Sullivan European ... to Sagem Securite (Safran Group) for its ... recognises the company,s expertise in advanced biometric ... novel, value-added products to end users. ... "Sagem Securite has been involved in delivering ...
(Date:12/15/2009)... the British Society for Research on Ageing (BSRA) to ... for an initial period of three years. ... Biogerontology editorial board and will acquire articles for ... society and provide society members with free electronic access ... Biogerontology offers a platform for research which ...
(Date:12/15/2009)... and Ghent University in Flanders, Belgium have found an ... major cause of death in intensive care units. By ... mice with septic shock, researchers Anje Cauwels and Peter ... damage, while their chances of survival increased significantly. That,s ... that nitric oxide is responsible for the potentially lethal ...
Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Septic shock: Nitric oxide beneficial after all 2Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 58699 1Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 58699 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 14 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 3Enerkem Announces Unique Community Energy Project 14318 1Enerkem Announces Unique Community Energy Project 14318 2
... new paper in the February 15th issue of Genes ... that occur in sperm while they reside in the ... molecular genetics of successful fertilization. , It had been ... Dr. Yael Gur and Haim Breitbart (Bar-Ilan University, Israel) ...
... cardiovascular events -- a combined endpoint including stroke, heart ... both men and women, according to a new meta-analysis ... Medical Center cardiologist. , However, the researchers found, the ... sexes. For men, aspirin lowered the risk of a ...
... puts on its biggest growth spurt during the dry season, ... "Most of the vegetation around the world follows a general ... rainy season and then during the dry season, leaves fall ... plant growth," said lead researcher Alfredo R. Huete of The ...
Other Biology News:Aspirin reduces cardiovascular risks in men and women -- but differently 2Aspirin reduces cardiovascular risks in men and women -- but differently 3Amazon rainforest greens up in the dry season 2Amazon rainforest greens up in the dry season 3
SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*...
Component of GELase™ Agarose Gel-Digesting Preparation. 1 ml of 50X Buffer is sufficient for replacing the buffer in at least 5 g of gel....
RABBIT ANTI QUINOLINIC ACID...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Biology Products: